Scarica l'app Stockscreener
37.64
3.04%
1.11
Dopo l'orario di chiusura:
37.64
Precedente Chiudi:
$36.53
Aprire:
$36.3
Volume 24 ore:
199.77K
Relative Volume:
0.66
Capitalizzazione di mercato:
$1.68B
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+6.78%
1M Prestazione:
+3.58%
6M Prestazione:
+79.32%
1 anno Prestazione:
+89.53%
Intervallo 1D:
$36.07
$38.86
Intervallo di 1 settimana:
$34.87
$38.91
Portata 52W:
$7.255
$45.00
Sionna Therapeutics Inc Stock (SION) Company Profile
Nome
Sionna Therapeutics Inc
Settore
Industria
Telefono
617-819-2020
Indirizzo
21 HICKORY DRIVE, SUITE 500, WALTHAM
Compare SION vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SION
Sionna Therapeutics Inc
|
37.64 | 1.63B | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.02 | 117.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
783.65 | 82.35B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
833.54 | 51.64B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
308.48 | 42.58B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.42 | 38.87B | 4.98B | 69.60M | 525.67M | 0.5198 |
Sionna Therapeutics Inc Stock (SION) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-01 | Downgrade | RBC Capital Mkts | Sector Perform → Underperform |
| 2025-11-19 | Iniziato | BTIG Research | Buy |
| 2025-09-03 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2025-09-03 | Iniziato | Raymond James | Strong Buy |
| 2025-03-04 | Iniziato | Guggenheim | Buy |
| 2025-03-04 | Iniziato | Stifel | Buy |
| 2025-03-04 | Iniziato | TD Cowen | Buy |
Mostra tutto
Sionna Therapeutics Inc Borsa (SION) Ultime notizie
SION: NBD1 stabilizer programs target major CF mutations, with pivotal data expected mid-2026 - TradingView
What’s the MACD signal for Sionna Therapeutics Inc.July 2025 Outlook & Risk Adjusted Buy/Sell Alerts - mfd.ru
Volume Recap: Should you avoid Sionna Therapeutics Inc stock right nowEarnings Miss & Growth-Oriented Investment Plans - baoquankhu1.vn
Orbimed Advisors Llc Sells 29,063 Shares of Sionna Therapeutics (NASDAQ:SION) Stock - Defense World
Sionna Therapeutics (NASDAQ:SION) Shares Down 14.6% on Insider Selling - Defense World
Sionna Therapeutics (NASDAQ:SION) Trading Down 14.6% Following Insider Selling - MarketBeat
OrbiMed Advisors LLC sells Sionna Therapeutics (SION) stock worth $1.37m - Investing.com
OrbiMed Advisors LLC sells Sionna Therapeutics (SION) stock worth $1.37m By Investing.com - Investing.com South Africa
Thompson Peter a. sells Sionna Therapeutics (SION) shares for $1.37m By Investing.com - Investing.com South Africa
Thompson Peter a. sells Sionna Therapeutics (SION) shares for $1.37m - Investing.com India
Sionna Therapeutics (NASDAQ:SION) Director Orbimed Advisors Llc Sells 29,063 Shares - MarketBeat
Sionna Therapeutics to Present at the Guggenheim Securities Emerging Outlook: Biotech Summit 2026 - markets.businessinsider.com
Sionna Therapeutics (NASDAQ:SION) Director Sells $84,237.30 in Stock - MarketBeat
Support Test: Whats the outlook for Sionna Therapeutics Incs sectorTrade Risk Summary & Smart Allocation Stock Reports - baoquankhu1.vn
Sionna Therapeutics, Inc. (NASDAQ:SION) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
TPG GP A, LLC Reduces Stake in Sionna Therapeutics Inc - GuruFocus
Sionna Therapeutics, Inc. (SION) Stock Analysis: Biotech’s Promising Prospects with 5.7% Upside Potential - DirectorsTalk Interviews
Sionna Therapeutics (SION) 10% owners sell $10 million in stock By Investing.com - Investing.com South Africa
Major Stake Unloaded in Sionna Therapeutics Sparks Fresh Market Buzz - TipRanks
Tpg Gp A, Llc Sells 250,000 Shares of Sionna Therapeutics (NASDAQ:SION) Stock - MarketBeat
Sionna Therapeutics (SION) 10% owners sell $10 million in stock - Investing.com
Sionna Therapeutics (NASDAQ:SION) Shares Gap DownHere's Why - MarketBeat
Sionna Therapeutics, Inc. (SION) Stock Analysis: Exploring a 7.39% Potential Upside in Biotech Innovation - DirectorsTalk Interviews
Aug Sentiment: Should you avoid Sionna Therapeutics Inc stock right now - baoquankhu1.vn
Sionna Therapeutics Chief Legal Officer Caps Off Strong 2025 with Sale of Over 10,000 Shares - AOL.com
Sionna Therapeutics (NASDAQ:SION) Stock Price Up 8.1%Here's Why - MarketBeat
Multiple Shots on Goal in Cystic Fibrosis: Sionna’s NBD1-Targeted Pipeline and 2026 Clinical Readouts Drive Buy Thesis and $58 DCF-Based Target - TipRanks
BTIG Research Reiterates Buy Rating for Sionna Therapeutics (NASDAQ:SION) - MarketBeat
SION: Advancing NBD1 stabilizers to transform CF care, with key data expected mid-2026 - TradingView
SION: First-in-class NBD1 stabilizers target full CFTR correction, with pivotal data expected mid-2026 - TradingView — Track All Markets
Sionna Therapeutics (NASDAQ:SION) Stock Price Down 10.1%Here's What Happened - MarketBeat
Assessing Sionna Therapeutics (SION) Valuation After Recent Share Price Swings And Premium P/B Multiple - Yahoo Finance
Sionna Therapeutics Advances Cystic Fibrosis Treatment with New Study - MSN
Sionna Therapeutics, Inc. (SION) Stock Analysis: A 27.73% Potential Upside in the Biotech Sector - DirectorsTalk Interviews
Assessing Sionna Therapeutics (SION) Valuation After A Sharp Share Price Move And Elevated Price To Book Ratio - Sahm
Market Recap: How Sionna Therapeutics Inc. stock compares to industry benchmarks2025 Sector Review & Trade Opportunity Analysis - Улправда
Is Sionna Therapeutics Inc. stock positioned for long term growthPortfolio Value Summary & Smart Money Movement Tracker - Улправда
Sionna Therapeutics (NASDAQ:SION) Trading Up 7.7%Here's Why - MarketBeat
Sionna Therapeutics, Inc. (NASDAQ:SION) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World
Sionna Therapeutics (NASDAQ:SION) Shares Down 7.5%What's Next? - MarketBeat
Sionna Therapeutics, Inc. (NASDAQ:SION) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Orbimed Advisors LLC Reduces Stake in Sionna Therapeutics Inc - GuruFocus
Raymond James raises Sionna Therapeutics stock price target on CF drug potential - Investing.com Canada
Sionna Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
A Sionna Therapeutics (SION) Insider Sold 33,000 Shares for $1.5 Million - AOL.com
A Sionna Therapeutics (SION) Insider Sold 33,000 Shares for $1.5 Million - The Motley Fool
Sionna Therapeutics Insider Sold Shares Worth $1,486,010, According to a Recent SEC Filing - marketscreener.com
Sionna Therapeutics Inc Azioni (SION) Dati Finanziari
Non sono disponibili dati finanziari per Sionna Therapeutics Inc (SION). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
Sionna Therapeutics Inc Azioni (SION) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Thompson Peter A. | Director |
Feb 02 '26 |
Sale |
44.57 |
1,890 |
84,237 |
3,559,765 |
| ORBIMED ADVISORS LLC | Director |
Feb 03 '26 |
Sale |
44.58 |
29,063 |
1,295,629 |
3,530,702 |
| ORBIMED ADVISORS LLC | Director |
Feb 02 '26 |
Sale |
44.57 |
1,890 |
84,237 |
3,559,765 |
| TPG GP A, LLC | 10% Owner |
Jan 22 '26 |
Sale |
40.00 |
250,000 |
10,000,000 |
6,494,962 |
1.24%
0.19%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):